← Eichor
Study identifier: NCT03546309 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy

Condition: Moyamoya Disease · Pediatric  ·  Sponsor: Capital Medical University

PhaseNA
Planned participants42
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

Revascularization surgery has been the standard treatment to prevent ischemic stroke in pediatric Moyamoya disease (MMD) patients with ischemic symptoms. However, perioperative complications, such as hyperperfusion syndrome, new infarct on imaging, or ischemic stroke, are inevitable. Remote ischemic conditioning (RIC) is a noninvasive and easy-to-use neuroprotective strategy, and it has potential effects on preventing hyperperfusion syndrome and ischemic infarction.

This description comes directly from the study's public registry record.

Talk to the study team

Xunming Ji, MD PhD  ·  +8613911077166  ·  807595234@qq.com;

Sijie Li, MD  ·  +8613581610258  ·  phoenix0537@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Fifth Medical Center of Chinese PLA General HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03546309